首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Muscle & nerve

缩写:

ISSN:0148-639X

e-ISSN:1097-4598

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5308条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Amuro Kondo,Keiichi Hokkoku,Takamichi Kanbayashi et al. Amuro Kondo et al.
Introduction/aims: Various signs of selective muscle involvement have been reported in amyotrophic lateral sclerosis (ALS) but such studies for the lower limbs are scarce. We formed a preliminary impression that hip abduc...
Katherine M Burke,Stephanie Johnson,Kayla Chomko et al. Katherine M Burke et al.
Background: Assistive technology offers an important means of compensating for lost upper extremity function in adults with progressive neuromuscular diseases (NMD), enabling participation in daily activities, supporting ...
Federico Pistoia,Elena Faedo,Marta Macciò et al. Federico Pistoia et al.
Aims: Facioscapulohumeral muscular dystrophy (FSHD) is a genetic progressive muscle disorder often presenting with facial weakness. However, imaging studies specifically evaluating facial muscle involvement and its relati...
Naoki Iijima,Yuta Hagiwara,Seiya Ishii et al. Naoki Iijima et al.
Introduction/aims: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease accompanied by bulbar dysfunction, in which tongue atrophy contributes to dysarthria and dysphagia. Conventional tongue assessments rel...
Yoshiyuki Matsuki,Kota Bokuda,Ryo Morishima et al. Yoshiyuki Matsuki et al.
Introduction/aims: Sensory cortical hyperexcitability, reflected by enlarged median nerve somatosensory evoked potentials (SEPs), has been reported in amyotrophic lateral sclerosis (ALS) and is associated with shorter sur...
Charalampia Koutsioumpa,Basil T Darras,Robert C Griggs et al. Charalampia Koutsioumpa et al.
The advent of novel disease-modifying therapeutics for spinal muscular atrophy (SMA) increased life expectancy with better motor function and potentially better quality of life. While the benefits of these therapies are well established, mo...